Soluble Mediators in Platelet Concentrates Modulate Dendritic Cell Inflammatory Responses in an Experimental Model of Transfusion

Journal of Interferon and Cytokine Research

Volumn 35, Issue 10, 2015, Pages 821-830

  Perros, Alexis J ^a,b   Christensen, Anne Marie ^a,b   Flower, Robert L ^a,b   Dean, Melinda M ^a,b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOCYTE CONCENTRATE; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ARTICLE; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOSE RESPONSE; EX VIVO STUDY; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE; LIMIT OF DETECTION; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; BLOOD TRANSFUSION; IMMUNOLOGY; METABOLISM; THROMBOCYTE;

BIOMARKERS; BLOOD PLATELETS; BLOOD TRANSFUSION; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION MEDIATORS; PLATELET TRANSFUSION;

EID: 84942923692     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2015.0029     Document Type: Article

References (62)

1. Adams S, O'Neill D, Bhardwaj N. 2005. Recent advances in dendritic cell biology. J Clin Immunol 25(2):87-98.
2. Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O. 2006. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion 46(5):800-810.
3. Aslam R, Speck ER, Kim M, Freedman J, Semple JW. 2008. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells. Transfusion 48(9):1778-1786.
4. Auffray C, Sieweke MH, Geissmann F. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27(1):669-692.
5. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18(1):767-811.
6. Bilgin YM, Brand A. 2008. Transfusion-related immunomodulation: A second hit in an inflammatory cascade? Vox Sang 95(4):261-271.
7. Bilgin YM, van de Watering LMG, Versteegh MIM, van Oers MHJ, Vamvakas EC, Brand A. 2011. Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion 51(12):2603-2610.
8. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. 2006. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 46(10): 1813-1821.
9. Boehlen F, Clemetson KJ. 2001. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 11(6):403-417.
10. Boomgaard MN, Gouwerok CW, Homburg CH, de Groot G, IJsseldijk MJ, de Korte D. 1994. The platelet adhesion capacity to subendothelial matrix and collagen in a flow model during storage of platelet concentrates for 7 days. Thromb Haemost 72(4):611-616.
11. Borish LC, Steinke JW. 2003. Cytokines and chemokines. J Allergy Clin Immunol 111(Supplement 2):S460-S475.
12. Cognasse F, Boussoulade F,Chavarin P,Acquart S, Fabrigli P,Lamy B, Garraud O. 2006. Release of potential immunomodulatory factors during platelet storage. Transfusion 46(7):1184-1189.
13. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Acquart S, Chavarin P, Courbil R, Fabrigli P, Garraud O. 2009. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: An in vitro study. Transfusion 49(1):91.
14. Costa EJ, Guimaraães TMPD, de Almeida NC, de Toledo Vde P. 2012. Comparison of cytokine levels and metabolic parameters of stored platelet concentrates of the Fundaçaõ Hemominas, Belo Horizonte, Brazil. Rev Bras Hematol Hemoter 34(2):94-99.
15. Council of Europe. 2008. Guide to the preparation, use and quality assurance of blood components. European Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), Strasbourg Cedex, France.
16. Dean MM, Samson LD, Flower RL. 2013. Identification of potential dendritic cell and monocyte inflammatory biomarkers to predict patient outcomes in the transfusion setting. Transfus Med 23:290.
17. Ferrer F, Rivera J, Corral J, González-Conejero R, Vicente V. 2000. Evaluation of leukocyte-depleted platelet concentrates obtained by in-line filtration. Vox Sang 78(4):235-241.
18. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. 2000. Effects of sample handling on the stability of interleukin-6, tumour necrosis factor-alpha and leptin. Cytokine 12(11):1712-1716.
19. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F. 1999. Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 93(5):1770.
20. Gudbrandsdottir S, Hasselbalch HC, Nielsen CH. 2013. Activated platelets enhance IL-10 secretion and reduce TNF-a secretion by monocytes. J Immunol 191(8):4059-4067.
21. Hamzeh-Cognasse H, Cognasse F, Palle S, Chavarin P, Olivier T, Delezay O, Pozzetto B, Garraud O. 2008. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol 9(1):54.
22. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56(5):559.
23. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. 1993. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 33(10):794-797.
24. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko A-C, Krijgsveld J, Feuerer M. 2013. Origin of monocytes and macrophages in a committed progenitor. Nat Immunol 14(8):821.
25. Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT. 2014. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol 193(4):1864-1872.
26. Hunt BJ. 1998. Indications for therapeutic platelet transfusions. Blood Rev 12(4):227-233.
27. Jurk K, Kehrel BE. 2005. Platelets: physiology and biochemistry. Semin Thromb Hemost 31(4):381-392.
28. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Meineri M, Wasowicz M, McCluskey SA, Beattie WS. 2006. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth 53(3):279.
29. Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP. 2007. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 5(4):788-796.
30. Kaur D, Sharma RR, Marwaha N. 2015. Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods. Asian J Transfus Sci 9(1):31-35.
31. Kiefel V. 2008. Reactions induced by platelet transfusions. Tranfus Med Hemother 35(5):354-358.
32. Kissel K, Berber S, Nockher A, Santoso S, Bein G, Hackstein H. 2006. Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion 46(5):818-827.
33. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. 2008. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358(12): 1229-1239.
34. Konca K, Tiftik EN, Aslan G, Kank A, Yalçn A. 2006. The effect of cromoglycate on time-dependent histamine and serotonin concentrations in stored blood products. Transfus Apher Sci 34(2):193-198.
35. Korte D. 2011. 10 years experience with bacterial screening of platelet concentrates in the Netherlands. Tranfus Med Hemother 38(4):251-254.
36. Lee HK, Iwasaki A. 2007. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol 19(1):48-55.
37. Loh YS, Dean MM, Johnson L, Marks DC. 2015. Treatment of platelets with riboflavin and ultraviolet light mediates complement activation and suppresses monocyte interleukin-12 production in whole blood. Vox Sang [Epub ahead of print]; DOI: 10. 1111/vox. 12283.
38. Martinson JA, Bae J, Klingemann HG, Tam YK. 2004. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. Cytotherapy 6(5):487-497.
39. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. 2001. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 108(12):1865-1873.
40. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. 1993. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 33(3):195-199.
41. National Health and Medical Research Council and the Australasian Society of Blood Transfusion. 2002. Clinical practice guidelines on the use of blood components (red blood cells, platelets, fresh frozen plasma, cryoprecipitate). Commonwealth of Australia, Canberra.
42. Refaai MA, Phipps RP, Spinelli SL, Blumberg N. 2011. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res 127(4):287-291.
43. Reid CD, Stackpoole A,Meager A, Tikerpae J. 1992. Interactions of tumor necrosis factor with granulocyte-macrophage colonystimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bonemarrow. J Immunol 149(8):2681-2688.
44. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CDL. 1999. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 29(9):2769-2778.
45. Rosenfeld BA, Herfel B, Faraday N, Fuller A, Braine H. 1995. Effects of storage time on quantitative and qualitative platelet function after transfusion. Anesthesiology 83(6):1167-1172.
46. Sahler J, Grimshaw K, Spinelli SL, Refaai MA, Phipps RP, Blumberg N. 2011. Platelet storage and transfusions: new concerns associated with an old therapy. Drug Discov Today Dis Mech 8(1-2):e9-e14.
47. Sahler J, Spinelli S, Phipps R, Blumberg N. 2012. CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfus Clin Biol 19(3):98-103.
48. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28(9):2760-2769.
49. Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, Brandt E, Flad HD, Petersen F. 2000. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95(4):1158-1166.
50. Schneider SO, Rensing H, Gräber S, Kreuer S, Kleinschmidt S, Kreimeier S, Mü ller P, Mathes AM, Biedler AE. 2009. Impact of platelets and fresh frozen plasma in contrast to red cell concentrate on unstimulated and stimulated cytokine release in an in vitro model of transfusion. Scand J Immunol 70(2):101-105.
51. Seghatchian J. 2006. Platelet storage lesion: An update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci 34(1):125-130.
52. Shrivastava M. 2009. The platelet storage lesion. Transfus Apher Sci 41(2):105-113.
53. Slichter SJ, Fish D, Abrams VK, Gaur L, Nelson K, Bolgiano D. 2005. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model. Blood 105(2):847-854.
54. Sparrow RL. 2010. Red blood cell storage and transfusion-related immunomodulation. Blood Transfus 8(Suppl 3):s26-s30.
55. Spiess BD. 2010. Platelet transfusions: the science behind safety, risks and appropriate applications. Best Pract Res Clin Anaesthesiol 24(1):65-83.
56. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A. 2004. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44(8):1143-1148.
57. Stack G, Snyder EL. 1994. Cytokine generation in stored platelet concentrates. Transfusion 34(1):20-25.
58. Störmer M, Vollmer T. 2014. Diagnostic methods for platelet bacteria screening: current status and developments. Tranfus Med Hemother 41(1):19-27.
59. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. 1992. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 153(1-2):115.
60. Tung J-P, Fraser JF, Nataatmadja M, Colebourne KI, Barnett AG, Glenister KM, Zhou AY, Wood P, Silliman CC, Fung YL. 2012. Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care 16(1):R19.
61. Wadhwa M, Seghatchian MJ, Dilger P, Sands D, Krailadisiri P, Contreras M, Thorpe R. 2000. Cytokines in WBC-reduced apheresis PCs during storage: A comparison of two WBCreduction methods. Transfusion 40(9):1118-1126.
62. Xia CQ, Kao KJ. 2003. Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells. Int Immunol 15(8):1007-1015.